Heparin-induced thrombocytopenia: advances in diagnosis and treatment.
Cooney
Maureen F
MF
Westchester Medical Center in Valhalla, NY 10595, USA. waterford55@aol.com
D000284:Administration, Oral; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D001120:Arginine / Q000031:analogs & derivatives; D003422:Critical Care / Q000379:methods; D016903:Drug Monitoring / Q000379:methods / Q000451:nursing; D004797:Enzyme-Linked Immunosorbent Assay; D006493:Heparin / Q000009:adverse effects*; D006629:Hirudins; D006801:Humans; D019934:International Normalized Ratio; D024802:Nurse's Role; D009730:Nursing Assessment; D010314:Partial Thromboplastin Time; D018579:Patient Selection; D010875:Pipecolic Acids / Q000627:therapeutic use; D010976:Platelet Count; D017410:Practice Guidelines as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use; D012307:Risk Factors; D013449:Sulfonamides; D013577:Syndrome; D013921:Thrombocytopenia / Q000139:chemically induced / Q000175:diagnosis / Q000276:immunology / Q000628:therapy; D013997:Time Factors
D000925:Anticoagulants; D006629:Hirudins; D010875:Pipecolic Acids; D011994:Recombinant Proteins; D013449:Sulfonamides; D006493:Heparin; D001120:Arginine; C031942:argatroban; C083544:lepirudin